A semi-mechanistic absorption model to evaluate drug-drug interaction with dabigatran: application with clarithromycin.

Aim The aim of this study was to develop a PK/PD model to assess drug–drug interactions between dabigatran and P-gp modulators, using the example of clarithromycin, a strong inhibitor of P-gp.